195 related articles for article (PubMed ID: 35401669)
1. Expanded CUG Repeat RNA Induces Premature Senescence in Myotonic Dystrophy Model Cells.
Hasuike Y; Mochizuki H; Nakamori M
Front Genet; 2022; 13():865811. PubMed ID: 35401669
[TBL] [Abstract][Full Text] [Related]
2. Cellular Senescence and Aging in Myotonic Dystrophy.
Hasuike Y; Mochizuki H; Nakamori M
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216455
[TBL] [Abstract][Full Text] [Related]
3. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
[TBL] [Abstract][Full Text] [Related]
4. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
[TBL] [Abstract][Full Text] [Related]
5. Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.
Nguyen L; Luu LM; Peng S; Serrano JF; Chan HY; Zimmerman SC
J Am Chem Soc; 2015 Nov; 137(44):14180-9. PubMed ID: 26473464
[TBL] [Abstract][Full Text] [Related]
6. A novel CUG(exp)·MBNL1 inhibitor with therapeutic potential for myotonic dystrophy type 1.
Jahromi AH; Nguyen L; Fu Y; Miller KA; Baranger AM; Zimmerman SC
ACS Chem Biol; 2013 May; 8(5):1037-43. PubMed ID: 23480597
[TBL] [Abstract][Full Text] [Related]
7. Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model.
Angelbello AJ; Rzuczek SG; Mckee KK; Chen JL; Olafson H; Cameron MD; Moss WN; Wang ET; Disney MD
Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7799-7804. PubMed ID: 30926669
[TBL] [Abstract][Full Text] [Related]
8. RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy.
Sobczak K; Wheeler TM; Wang W; Thornton CA
Mol Ther; 2013 Feb; 21(2):380-7. PubMed ID: 23183533
[TBL] [Abstract][Full Text] [Related]
9. A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels.
Reddy K; Jenquin JR; McConnell OL; Cleary JD; Richardson JI; Pinto BS; Haerle MC; Delgado E; Planco L; Nakamori M; Wang ET; Berglund JA
Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20991-21000. PubMed ID: 31570586
[TBL] [Abstract][Full Text] [Related]
10. Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a
Chakraborty M; Sellier C; Ney M; Pascal V; Charlet-Berguerand N; Artero R; Llamusi B
Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29592894
[TBL] [Abstract][Full Text] [Related]
11. Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene.
Llamusí B; Artero R
Curr Genomics; 2008 Dec; 9(8):509-16. PubMed ID: 19516957
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy.
Osborne RJ; Lin X; Welle S; Sobczak K; O'Rourke JR; Swanson MS; Thornton CA
Hum Mol Genet; 2009 Apr; 18(8):1471-81. PubMed ID: 19223393
[TBL] [Abstract][Full Text] [Related]
13. Study of an RNA-Focused DNA-Encoded Library Informs Design of a Degrader of a r(CUG) Repeat Expansion.
Gibaut QMR; Akahori Y; Bush JA; Taghavi A; Tanaka T; Aikawa H; Ryan LS; Paegel BM; Disney MD
J Am Chem Soc; 2022 Dec; 144(48):21972-21979. PubMed ID: 36399603
[TBL] [Abstract][Full Text] [Related]
14. Large CTG repeats trigger p16-dependent premature senescence in myotonic dystrophy type 1 muscle precursor cells.
Bigot A; Klein AF; Gasnier E; Jacquemin V; Ravassard P; Butler-Browne G; Mouly V; Furling D
Am J Pathol; 2009 Apr; 174(4):1435-42. PubMed ID: 19246640
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
[TBL] [Abstract][Full Text] [Related]
16. Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects.
Hoskins JW; Ofori LO; Chen CZ; Kumar A; Sobczak K; Nakamori M; Southall N; Patnaik S; Marugan JJ; Zheng W; Austin CP; Disney MD; Miller BL; Thornton CA
Nucleic Acids Res; 2014 Jun; 42(10):6591-602. PubMed ID: 24799433
[TBL] [Abstract][Full Text] [Related]
17. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome-Wide Studies of RNA-Targeted Small Molecules Provide a Simple and Selective r(CUG)
Gibaut QMR; Bush JA; Tong Y; Baisden JT; Taghavi A; Olafson H; Yao X; Childs-Disney JL; Wang ET; Disney MD
ACS Cent Sci; 2023 Jul; 9(7):1342-1353. PubMed ID: 37521782
[TBL] [Abstract][Full Text] [Related]
19. Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice.
Jauvin D; Chrétien J; Pandey SK; Martineau L; Revillod L; Bassez G; Lachon A; MacLeod AR; Gourdon G; Wheeler TM; Thornton CA; Bennett CF; Puymirat J
Mol Ther Nucleic Acids; 2017 Jun; 7():465-474. PubMed ID: 28624222
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional changes and developmental abnormalities in a zebrafish model of myotonic dystrophy type 1.
Todd PK; Ackall FY; Hur J; Sharma K; Paulson HL; Dowling JJ
Dis Model Mech; 2014 Jan; 7(1):143-55. PubMed ID: 24092878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
